3,6-disubstituted xanthylium salts
US9549933B2 · kind B2 · utility
1Cited by
4References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 2014 |
| Grant date | Jan 24, 2017 |
| Priority date | — |
| Expiry date | May 26, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7047
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described are a compound of formula (II) or (III):The compounds are effective in the treatment of disease, including a tauopathy condition or a disease of tau protein aggregation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.